Home
Home
Search (⌘K or ⌃K)
Data
Methodology
Data Model
About
Help
Sign In
INDEXED
Home
/
InVitroSystem
/
GM25256 (WTC-11) — IGVFSM9172PRNN
GM25256 (WTC-11) — IGVFSM9172PRNN
released
Json view
Summary
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
Sample Terms
GM25256 (WTC-11)
Classification
differentiated cell specimen
Sex
male
Age
unknown
Time Post Change
28 day
Cell Fate Change Protocol
WTC and Cardiomyocytes Protocol.pdf
Taxa
Homo sapiens
Sources
Charles Gersbach, Duke
Aliases
charles-gersbach:in-vitro-system-bulk-atac-chir4um-ipsc-cm-rep2
Institutional Certificates
IP117-03
Donors
1 item
Accession
Aliases
Sex
Taxa
IGVFDO3212TBUN
charles-gersbach:human-donor-WTC11
male
Homo sapiens
File Sets
3 items
Accession
Summary
Aliases
Lab
IGVFDS4606DSTJ
ATAC-seq: alignments
charles-gersbach:analysis-set-bulk-atac-count
Charles Gersbach, Duke
IGVFDS9490WNXZ
ATAC-seq: fold change over control, peak quantifications
charles-gersbach:analysis-set-bulk-atac-DEanalysis
Charles Gersbach, Duke
IGVFDS9961QTUB
ATAC-seq
charles-gersbach:measurement-set-bulk-atac-chir4um-ipsc-cm-rep2
Charles Gersbach, Duke
Treatments
1 item
Term Name
Purpose
Type
Summary
GSK3 inhibition
antagonist
chemical
Treatment of 4 μM GSK3 inhibition for 7 days
Attribution
Award
HG012053
Principal Investigator(s)
Charles Gersbach
,
Gregory Crawford
,
Tim Reddy
Contact P.I.
Charles Gersbach
Lab
Charles Gersbach, Duke